FDA 510(k) FDA class 1 Substantially Equivalent 🇺🇸 United States

VANTERA CLINICAL ANALYZER

K Number: K113830 · Decision Aug 30, 2012
Classifications
1
FEI Numbers
39
Registration Numbers
39
Same Product Code
150
Applicant Total
3
Review Days
247

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
VANTERA CLINICAL ANALYZER
K Number
K113830
Device Class
FDA class 1
Clearance Type
Traditional
Regulation Number
862.1705
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Liposcience
Date Received
December 27, 2011
Decision Date
August 30, 2012
Product Code
CDT
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
CDT Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (CDT), ordered by most recent decision date.

View all

Other Clearances by Liposcience

K Number Device Name
K133849 VANTERA CLINICAL ANALYZER
K063841 NMR PROFILER AND NMR LIPOPROFILE ASSAY, CONTROLS